...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Events
2
Apr 25, 2017 09:48AM

SF,

I recently inquired with Sarah regading the lack of events and publication on the Zenith site and she she replied this this

Hi .....

 Once presenting opportunities are confirmed, the website will be updated to reflect this. As a private company, Zenith does not attend as many conferences as Resverlogix.

 Best regards,

 Sarah

That being said, it is a little more strange as we go along  with the trials to hear absolute zip with anything to do with Zenith, is it possible that Zenith is the possible co in play for a bigger deal, could that deal temporarily  finance or secure the cti loan till Betonmace is completed,   (just a little specualtion but anything is possible)

4
Apr 25, 2017 10:35AM
1
Apr 25, 2017 02:48PM
3
Apr 25, 2017 02:57PM
1
Apr 25, 2017 03:17PM
1
Apr 25, 2017 03:21PM
4
Apr 25, 2017 05:28PM
5
Apr 26, 2017 12:31AM
2
Apr 26, 2017 10:51AM
Share
New Message
Please login to post a reply